Anna Mero
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
Papers in ⓘ
-
- Protein purification and stability 8
- RNA Interference and Gene Delivery 3
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 8
- biodegradable polymer synthesis and properties 4
- Co-authors
- Francesco M. Veronese (13 shared papers)Gianfranco Pasut (28 shared papers)Monica Campisi (5 shared papers)Angelo Fontana (3 shared papers)Barbara Spolaore (3 shared papers)Zhihao Fang (2 shared papers)Tacey X. Viegas (2 shared papers)Oddone Schiavon (7 shared papers)
- Journals
- Bioconjugate Chemistry (6 papers)Journal of Controlled Release (6 papers)Journal of Pharmaceutical Sciences (1 paper)Molecular Pharmaceutics (1 paper)Macromolecular Bioscience (1 paper)
- Partner nations
- ItalyUnited StatesJapan
In The Last Decade
Anna Mero
34 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Biomaterials 849
- Pharmaceutical Science 241
- Molecular Medicine 166
- Surfaces, Coatings and Films 206
- Organic Chemistry 614
Countries citing papers authored by Anna Mero
This map shows the geographic impact of Anna Mero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mero more than expected).
Fields of papers citing papers by Anna Mero
This network shows the impact of papers produced by Anna Mero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mero. The network helps show where Anna Mero may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Mero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Impact of PEGylation on Biological Therapies Hit paper breakdown → | 2008 | 790 |
| 2 | 2011 | 355 | |
| 3 | 2014 | 220 | |
| 4 | 2007 | 199 | |
| 5 | 2007 | 176 | |
| 6 | 2014 | 127 | |
| 7 | 2011 | 95 | |
| 8 | 2009 | 72 | |
| 9 | 2007 | 69 | |
| 10 | 2012 | 68 | |
| 11 | 2011 | 66 | |
| 12 | 2013 | 59 | |
| 13 | 2012 | 54 | |
| 14 | 2014 | 46 | |
| 15 | 2014 | 44 | |
| 16 | 2016 | 41 | |
| 17 | 2009 | 33 | |
| 18 | 2015 | 33 | |
| 19 | 2015 | 33 | |
| 20 | 2008 | 32 |
About Anna Mero
Anna Mero is a scholar working on Molecular Biology, Biomaterials, Pulmonary and Respiratory Medicine, Oncology and Cell Biology, having authored 34 papers that have together received 2.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Protein purification and stability (8 papers), Blood properties and coagulation (8 papers), biodegradable polymer synthesis and properties (4 papers), Peptidase Inhibition and Analysis (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Protease and Inhibitor Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Biomaterials (849 citations), Pharmaceutical Science (241 citations), Molecular Medicine (166 citations), Surfaces, Coatings and Films (206 citations) and Organic Chemistry (614 citations). Anna Mero has collaborated with scholars based in Italy, United States and Japan. Frequent co-authors include Francesco M. Veronese, Gianfranco Pasut, Monica Campisi, Angelo Fontana, Barbara Spolaore, Zhihao Fang, Tacey X. Viegas, Oddone Schiavon, Michael D. Bentley and Kunsang Yoon. Their work appears in journals such as Bioconjugate Chemistry, Journal of Controlled Release, Journal of Pharmaceutical Sciences, Molecular Pharmaceutics and Macromolecular Bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.